HYPErcholesterolemia Management: Going Beyond Statin Therapy Worth All the HYPE?

Monday, December 5, 2022

3:30 PM – 5:00 PM

Location: Mandalay Bay South Convention Center, Oceanside A, Level 2

CE Credits: 1.50 contact hours

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists
Activity #: 0204-0000-22-254-L01-P
Activity Type: Application-based
Target Audience: Pharmacist

Learning Objectives:

Interpret treatment recommendations included in the 2018 ACC-AHA, 2019 ESC/EAS, and 2020 AACE/ACE hypercholesterolemia guidelines.
Apply guidelines for the management of patients with hypercholesterolemia.
Analyze clinical controversies regarding the benefits of treating hypercholesterolemia in subpopulations with statin and nonstatin therapy.
Evaluate challenges associated with the updated guidelines and recent clinical trials when treating hypercholesterolemia with statin and nonstatin therapy.

Program Chair(s)

Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA

Professor and Coordinator of Clinical Outreach
The University of Tennessee Health Science Center, Department of Clinical Pharmacy & Translational Science

Moderator(s)

Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA

Professor and Coordinator of Clinical Outreach
The University of Tennessee Health Science Center, Department of Clinical Pharmacy & Translational Science

Faculty Member(s)

Matthew Kostoff, PharmD, BCACP, BCPS, CLS, FNLA

Manager, Ambulatory and Population Health Pharmacy; Associate Professor, Pharmacy Practice
University Hospitals; Northeast Ohio Medical University
Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA

Professor and Coordinator of Clinical Outreach
The University of Tennessee Health Science Center, Department of Clinical Pharmacy & Translational Science